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Immunohistochemical quantification of serotonin and serotonin transporters in the lumbar 
region of the mouse spinal cord after spinal cord injury 
 
Diana N. Hong 
Department of Neurobiology and Behavior, Cornell University 
 
Central pattern generators (CPGs) are important neuronal networks that are made up of 
interneurons that organize rhythmic motor output such as respiration, mastication, and 
locomotion. Locomotor CPGs are located in the spinal cord of all vertebrates. Interneurons have 
been shown to be a necessary part of regulating the coordination of the left and right flexor and 
extensor muscles that generate the normal walking movement. The V2a interneurons, in 
particular, play an important role in maintaining a left-right alternating hindlimb pattern at high 
speeds. Two key players of the CPGs are serotonin (5-HT) and serotonin transporters (SERT). 5-
HT plays an important role in enabling the network to generate the locomotor rhythm in rodents, 
while SERT is responsible for high affinity uptake of 5-HT to terminate its activity in the 
synaptic cleft. Using double immunohistochemical methods, I determined that not only are 5-HT 
and SERT co-localized in 5-HT terminals, but also 5-HT and SERT–labeled terminals are 
located on V2a interneurons. Using Sholl analysis, I determined that SERT and 5-HT show 
similar co-localization patterns on the V2a interneurons. Although spinal cord injury (SCI) 
typically does not inflict physical damage to the cells that make up the hindlimb CPG, it results 
in a loss of motor function by removing descending input from the brain. This in turn can induce 
changes in CPG cellular activity and transmitter sensitivity. Thus, I sought to observe how SCI 
affects expression levels of 5-HT and SERT. After SCI, a loss of motor function occurs due to 
the changes in cellular activity and sensitivity in the CPG. Using single immunohistochemical 
methods, I determined that both 5-HT and SERT decrease significantly in area and intensity after 
SCI.  
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Introduction 
 
Central pattern generators (CPGs) are important neuronal networks, made up of 
interneurons, which organize rhythmic motor output such as respiration, mastication, and 
locomotion (Barlow, 2009; Kiehn, 2006). The CPG for locomotion is located (Zhong et al., 
2010) in the spinal cord of all vertebrates (Kiehn, 2006). Interneurons have been shown to 
regulate the coordination of the left and right flexor and extensor muscles (Zhong et al., 2010). 
Some of these interneurons can be visually labeled and identified using fluorescent marker 
proteins based on their patterns of transcription factor expression (Guertin, 2005; Kiehn, 2011). 
Identified by the expression of the transcription factor Chx10, the V2a class of interneurons is 
not essential for locomotor-like rhythm generation but has been shown to play an important role 
in maintaining left-right alteration at high locomotor cycle frequencies (Zhong et al., 2010). 
These glutamatergic, ipsilaterally projecting neurons are rhythmically active during fictive 
locomotion (Zhong et al., 2010).	  
Two key molecular players in the CPG are serotonin and serotonin transporters. Previous 
studies have shown that serotonin, or 5-hydroxytryptamine (5-HT), has an important role in the 
generation of the locomotor rhythm in rodents (Schmidt and Jordan, 2000; Zhong et al., 2010). 
Descending serotonergic fibers originating from the medullary Raphe nuclei provide the 
serotonergic input to the lumbar spinal cord region (Schmidt and Jordan, 2000). During the time 
of locomotion, serotonin release in the lumbar spinal cord has been observed in rodents, which 
can help to prepare the CPG network to generate fictive locomotion (Schmidt and Jordan, 2000).  
Fictive locomotor-like activity can be induced when the ventral half of the spinal cord is infused 
with 5-HT and NMDA (Zhong et al., 2010). 5-HT transmission is terminated by serotonin 
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transporters (SERT), a 12 transmembrane sodium and calcium-dependent transporter. SERT has 
been found within nanometers of the synapse as well as at greater distances, and it has been 
shown that the 5-HT molecules that are not taken up by the perisynaptic SERT are taken up into 
the same or neighboring cells through axonal SERT or nearby glial cells (Zhou et al., 1998). 
Since SERT is responsible for the high affinity uptake of 5-HT, and thus the removal of the 5-HT 
from the synaptic cleft, the activity of SERT determines the time course of 5-HT in the 
postsynaptic cell (Zhou et al., 1998).	  
Spinal cord injury (SCI) results in the immediate and irreversible loss of sensory 
perception and motor function below the injury site (Guertin, 2005). Although SCI typically does 
not inflict physical damage to the cells that make up the hindlimb CPG, it results in a loss of 
motor function by removing descending input from the brain, including the activating 
reticulospinal glutamate pathway and the Raphe serotonergic pathway (Fourad et al., 2010; 
Hayashi et al., 2010). This in turn can induce changes in CPG cellular activity and transmitter 
sensitivity. Following SCI, motoneurons below the lesion become hyperexcitable due to an 
increased expression of slow inward currents, and also demonstrate 5-HT denervation 
supersensitivity (Bennett and Siu, 2001; Kong et al., 2011). Furthermore, a downregulation of 
SERT has been shown in rats after SCI (Kong et al., 2011). This may result from the localization 
of SERT in the spinal cord on the terminals of the descending serotonergic fibers (Schmidt and 
Jordan, 2000). 	  
The goal of my project was to determine the changes in 5-HT and SERT expression after 
SCI using immunohistochemical methods in the regions of the spinal cord where the Chx-10 
interneurons are located. First, by performing double immunohistochemistry, the approximate 
locations of SERT and 5-HT relative to each other and relative to the V2a interneurons were 
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determined. The results from these co-localization studies showed that not only do SERT and 5-
HT co-localize, but SERT and 5-HT–labeled processes are located on V2a neurons in a similar 
manner, suggesting similar patterns of synaptic contact.  Then single immunohistochemistry was 
performed on both SCI and intact mice to address the changes in expression levels, as measured 
by area and intensity, of 5-HT and SERT. These experiments showed that both the area and 
intensity of 5-HT and SERT significantly decreased after SCI.  
 
Materials and Methods 
 
Transgenic mice. Chx10::eCFP mice, which were provided by Drs. Steven Crone and Kamal 
Sharma at the University of Chicago, were used for the following experiments. The mice were 
maintained and bred at Cornell following accepted IACUC policies. 
 
SCI surgery. 3- to 4-week-old mice were used for SCI surgery; the surgery was performed by a 
technician in our laboratory. Once under anesthesia, the mouse’s dorsal skin was shaved and 
sterilized in preparation for an incision to expose the part of the vertebral column dorsally above 
the thoracic region of the spinal cord. A gap was made between the T8 and T9 vertebrae, and a 
complete transverse cut to the spinal cord was made. The incision was closed with tissue glue. 
Post-operative care, including drug administration and bladder expression, was administered. 
Littermates were used as controls. Mice were maintained by the technician for 4 to 5 weeks until 
they were used.  
 
5 
	  
Perfusion. SCI mice and their age-matched control intact mice were anesthetized with 0.03 mg/g 
of ketamine/xylazine IP 4-5 weeks after surgery. Once deeply anesthetized, the mice were 
prepared for perfusion. In the fume hood, with the mouse’s ventral side up, an incision was made 
to expose the peritoneal cavity. The left and right ribcages were cut laterally and the diaphragm 
was then cut horizontally to expose the heart.  A cut was made in the right atrium to drain the 
blood, and a 25 gauge needle attached to a perfusion pump was inserted into the left ventricle. 
Once the liver blanched, perfusion buffer was perfused through the mice for 3 minutes, and 4% 
PFA in 0.1M phosphate buffer was then perfused for 20 minutes. A laminectomy was performed 
in order to remove the spinal cord. The isolated spinal cord was post-fixed in 4% 
paraformaldehyde at 4° C for 90 minutes. The cord was then dehydrated in 30% sucrose at 4° C 
16 hours. 
 
Cryostat sectioning. From the post-fixed and dehydrated spinal cords, a 1 mm segment of the 
upper lumbar spinal cord was cut. Two spinal cords were positioned side by side on the chuck 
and cut into 15 micron transverse slices using a cryostat. For the double immunohistochemistry 
experiments, two intact cords were placed side by side; for the single immunohistochemistry 
experiments, a SCI and control, intact cords were placed side by side. Slices were plated onto 
microscope slides (25x8x1mm, Fisherbrand Superfrost), so that 8 slices of both SCI and intact 
spinal cords were arranged in pairs evenly on the microscope slides (Figure 1). These slides were 
then stored at -20° C until they were used for IHC. 
Fig. 1. Arrangement of spinal cord pairs on one 
microscope slide. SCI- and intact- spinal cords were sectioned 
together and placed at one of eight positions.	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*Figure 1 was reproduced with permission from Scaperotti, 2012. 
 
Single immunohistochemistry. A blocking pap-pen was used to enclose each pair of spinal cord 
slices on each of the microscope slides. At room temperature, the slides were first washed with 
1X phosphate buffered saline (PBS) (1.5M NaCl, 3.8 mM NaH2PO4, 16.2mM Na2HPO4) for 4 
minutes. They were then incubated with 0.2% Triton X-100 for 10 minutes. Afterwards, the 
slices were washed with 1X PBS three times over 15 minutes. Exogenous peroxidase activity 
was quenched with peroxidase quenching buffer for 60 minutes at room temperature. 1% 
blocking reagent (Invitrogen Tyramide Signal Amplification Kit) was applied for 60 minutes, 
also at room temperature, in order to bind nonspecific ligands and prevent inappropriate binding 
of the primary antibody. Primary antibodies, raised in rabbits, were diluted (SERT 1:1000, 
ImmunoStar; 5-HT 1:5000, Sigma) and applied to spinal cord slices for 16 hours at 4° C. 
Additionally, one of the positions on the microscope slide was incubated in 1% blocking reagent 
alone as a no-primary control. Another position was designated as the preabsorption control. The 
SERT peptide used as the epitope to make the antibody (Immunostar) was preabsorbed with the 
anti-SERT antibody (1:1000) for 18 to 21 hours. This mixture was then applied to the designated 
position on the microscope slide. Slides were rinsed in 4°C 1X PBS three times over 15 minutes. 
They were then incubated in anti-rabbit secondary antibody conjugated to horseradish peroxidase 
(Invitrogen SA kit) diluted 1:100 in 1% blocking reagent for 45 minutes at room temperature in 
order to amplify and detect the primary antibodies. Slides were rinsed in 4°C 1X PBS three times 
over 15 minutes and incubated in Alexa Fluor 647 tyramide, diluted 1:100 in amplification 
buffer/0.0015% H2O2 for 16 minutes. The tyramide immunofluorescence procedure was used 
because it allows for signal amplification and is thus useful when there are few target antigens or 
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when there is a high amount of nonspecific background signals. During the tyramide 
amplification procedure, the secondary antibody is conjugated to HRP, and this then reacts with 
an inactive tyramide derivative to produce a fluorescent tag on the secondary antibody. The 
signal at each antigen is amplified because the HRP-derivative reaction occurs repeatedly at each 
secondary antibody.  After the 16 minutes of incubation, slides were rinsed in 4°C 1X PBS three 
times over 15 minutes and mounted with Fluor-Gel with Tris buffer (Electron Microscopy 
Sciences) and coverslipped (22x50 mm, Electron Microscopy Sciences).  
 
Double Immunohistochemistry. Two primary antibodies were used together, raised in different 
animals (goat polyclonal to GFP 1:250, Abcam; Rabbit anti-SERT 1:250, Immunostar; Rabbit 
anti-5-HT 1:1000, Sigma; Goat anti-5-HT 1:1000, Immunostar), and were then reacted with 
different second antibodies. The rabbit anti-SERT and rabbit anti-5-HT, were incubated in anti-
rabbit secondary antibody conjugated to horseradish peroxidase. For the goat polyclonal to GFP, 
a secondary antibody, donkey polyclonal to goat DyLight 488, was used (1:200 or 1:400).  
 
Microscopy. A LeicaTCS SP2 confocal microscope was used for imaging. For single 
immunohistochemistry, a 20x objective lens was used to view tissue, and regions of the medial 
lamina VIII of every spinal cord slice were imaged with 8X zoom for analysis using the 633 nm 
laser line. Within each experiment, SCI and intact slices of the same pap-circles were imaged 
using the same microscope gain and offset settings. For double immunohistochemistry, a 63x 
objective lens was used, with a 4X zoom while simultaneously using the 633nm and 488 nm 
lasers. For double labeling of SERT and 5-HT, medial lamina VIII of every spinal cord slice was 
imaged. For double labeling of V2a interneurons (GFP) and 5-HT or SERT, every detectable 
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V2a interneuron was imaged. No-primary and preabsorption-control positions were imaged with 
the highest gain-value for each primary antibody using the same microscope settings as for non-
control positions. Z-series projections of the 15 µm tissue were made in 1µm step sizes.  
 
Single immunohistochemistry analysis. ImageJ software (v.1.44p; NIH) was used to assemble the 
Z-series projections into a single image of a max-projection. These images were deconvolved 
using an ImageJ plug-in to remove any noise from the confocal microscope. Using MatLab, the 
average pixel intensity in the deconvolved no-primary antibody control images were subtracted 
from the deconvolved max projections.  Each image was converted into a binary image in order 
to determine the number of pixels above an automated threshold, which were used to determine 
the percent of pixels above threshold in the paired SCI images. The mean intensity of these 
pixels was also recorded and compared. Raw data were compared between slices of the same 
group on a slide while ratios were used for between-experiment comparisons.  
 
Double immunohistochemistry analysis. For double immunohistochemistry mapping of SERT 
and 5-HT, ImageJ software was used to split the channel images and deconvolve each optical 
slice for the green  (488 nm; 5-HT) and far red (633 nm; SERT) channels. Using MatLab, the 
average pixel intensity in the deconvolved no-primary antibody control images were subtracted 
from the deconvolved optical slice images. Then, for each optical slice, the Manders’ coefficient 
plugin was used to determine the percentage of pixels in one channel that co-localize with a 
signal from the second channel. M1 refers to the percentage of SERT pixels co-localizing with 
the signal from the 5-HT channel, and M2 refers to the percentage of 5-HT pixels co-localizing 
with signals from the SERT channel. Therefore, with a greater signal from the 5-HT, the ratio of 
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5-HT pixels co-localizing with signals from the SERT channel to the total number of 5-HT 
pixels decreases, and M2 thus decreases (Manders EMM et al., 1993). For double 
immunohistochemistry labeling for V2a interneurons and SERT and for V2a interneurons and 5-
HT, Fiji, an image processing package that is a distribution of ImageJ, was used in order to 
perform Sholl analysis, a quantification method that counts the number of path intersections for 
concentric circles of gradually increasing radii that are centered at the cell body (Langhammer et 
al., 2010). Radius sizes of increasing multiples of 8.206 pixels, or 1 micrometer, were used. In 
order to ensure that processes of only one V2a interneuron was being analyzed at a time, and any 
images that showed more than one V2a interneuron cell body was not used for analysis; the V2a 
interneurons are sparse in the spinal cord, so it is unlikely that processes from a different V2a 
interneurons are found in the image. The Simple Neurite Tracer plugin was used to highlight the 
areas of co-localization in the composite image stacks. Once the paths were traced and the V2a 
interneuron cell was designated as the central point, a Sholl analysis was performed to determine 
at what distance from the V2a interneuron cell the SERT or 5-HT was co-localizing in highest 
frequency. A graph was created that allowed for a visualization of how the number of 
intersections with concentric circles varied with the distance from the central point. The Sholl 
analysis data obtained from individual V2a interneurons were then compiled and averaged. 
 
Statistical analysis. Statistics were performed using JMP (JMP software; SAS) and Graph Pad 
Prism (GraphPad Software). For comparison of multiple treatments of Z-series projections 1-way 
ANOVA was applied. Additionally, single and double immunohistochemistry data were 
analyzed using the multilevel model (also known as mixed effect model). With this model, for 
the single immunohistochemistry, the intensity data and area data were response variables, while 
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the mouse pair and mouse within each pair were set as the random effect, and the type of mouse 
(SCI or intact mouse) was set as the fixed effect. For the double immunohistochemistry with 
double labeling for V2a interneurons and 5-HT and with double labeling for V2a interneurons 
and SERT, the difference between the two Manders’ coefficients and was the response variable, 
the mouse and analyzed optical slice were set as the random effect. A significance level of 0.05 
was accepted for all tests.  
 
*Some of the methods listed under the headings of Transgenic Mice, SCI surgery, Perfusion, 
Cryostat sectioning, Single immunohistochemistry, Microscopy, Single immunohistochemistry 
analysis, and Statistical analysis were taken from Husch et al. (2012). 
 
Results 
 
Co-localization of serotonin transporters (SERT) and serotonin (5-HT) 
In order to determine where the serotonin transporters (SERT) are located in relation to serotonin 
(5-HT) and if SERT are indeed located entirely within 5-HT terminals, co-localization analysis 
of the double immunohistochemical labeling of SERT and 5-HT was performed using Manders’ 
coefficient. With SERT immunostaining being imaged using the far red channel (633 nm) and 5-
HT immunostaining being imaged using the green channel (488 nm), red pixels denote the 
amount of SERT staining and green pixels denote the amount of 5-HT staining (Figure 2).  
Empty black areas, as seen in Figures 2A and C, are artifacts from the cryostat procedure and are 
not indicative of staining results. 
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M1 is interpreted as the percentage of SERT-labeled pixels co-localizing with the signal from the 
5-HT channel, and M2 is interpreted as the percentage of 5-HT pixels co-localizing with signals 
from the SERT channel. For each optical slice that was analyzed, M2 was less than M1, and the 
difference between the two coefficients was significant (p<0.05, n=5). The average M2 
A:	  5-­‐HT	   B:	  SERT	  
Figure 2. Co-localization analysis of the double 
immunohistochemical labeling of serotonin (5-HT), in 
green, and serotonin transporters (SERT), in red. A.5-
HT labeling from green channel. B. SERT labeling 
from red channel. C. Composite image of A and B, 
showing co-localization in yellow. 
C:	  Composite	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coefficient was 0.79, meaning approximately 79% of the imaged SERT co-localized with the 
imaged 5-HT. Since previous studies showed that virtually all the SERT is located in 5-HT 
terminals, this M2 coefficient is lower than expected. However, this low percentage of SERT co-
localization in 5-HT processes is a conservative estimate and may represent more of an artifact 
of the analysis than a true demonstration of SERT co-localization. From visual inspection, an 
almost complete overlap of SERT with 5-HT processes is observed, suggesting that SERT is 
indeed primarily expressed in 5-HT processes. Furthermore, Manders’ coefficients are sensitive 
to background signals, and pixel slippage can occur while obtaining multiple Z-series. Both of 
these factors could contribute to the lower than expected M2 value. The average M1 coefficient 
was 0.54, meaning approximately 54% of the imaged 5-HT co-localized with the imaged SERT. 
The fact that the M1 coefficient is less than the M2 coefficient illustrates that there is more 5-HT 
staining alone and not co-localizing with SERT. This is expected since SERT is selectively 
localized at pre-synaptic terminals of the 5-HT axons (Zhou et al., 1998). 
 
5-HT and SERT show similar co-localization patterns on V2a interneurons 
It has previously been shown that the loss of serotonin contributes to a significant increase in 5-
HT sensitivity in V2a interneurons (Husch et al., 2012), but it was not yet proven whether V2a 
interneurons were directly innervated by descending serotonergic fibers. Thus, I sought to 
determine whether V2a interneurons might receive direct synaptic input from descending 5-HT 
axons. Double immunohistochemistry labeling for V2a interneurons (using an antibody against 
CFP in Chx10-CFP mice) and SERT, and for V2a interneurons and 5-HT, were performed in 
order to determine the existence and distribution of serotonin processes and terminals on the V2a 
interneurons, suggesting synaptic contact. Yellow pixels, denoting the co-localization of 5-HT 
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(red channel) and a V2a interneuron (green channel) to within a single pixel, were used as 
possible markers for synaptic contact. Images were taken from the medial lamina VIII region 
(see Figure 7A). Before Sholl analysis was performed, areas of double labeling were traced using 
Simple Neurite Tracer plugin (Figure 3).  
       
 
 
Sholl analysis, a quantification method that counts the number of path intersections for 
concentric circles of gradually increasing radii that are centered at the cell body (Langhammer et 
al., 2010), was then performed on the double labeled composite image stacks of V2a 
interneurons and 5-HT.  This analysis determines the distance at which the V2a interneuron and 
the SERT or 5-HT co-localizes in highest frequency. The number of intersections between the 
traced co-localized V2a interneuron and 5-HT processes were binned into a set of concentric 
circles of increasing radius; this Sholl analysis illustrated where on the V2a interneuron the 5-HT 
terminals were located (n=8 cells, Figure 4A). From the average of these data, it was determined 
that the peak of the distribution of the crossings occurred about 3 microns from the V2a cell 
A	   B	  
Figure 3. Simple Neurite Tracer application prior to performing Sholl Analysis. A. One optical slice showing areas of 
co-localization of SERT (red) and V2a (green) processes is seen in yellow. B. The final traced image of the co-
localized areas.  
V2a	  soma	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body (Figure 5). Though synapses cannot be conclusively observed with light microscopes, these 
co-localizations represent putative 5-HT synapses on the V2a interneurons as one pixel is 
equivalent to 0.116 um. The same analysis was done for double labeled composite image stacks 
of V2a interneurons and SERT. Like the 5-HT, the average peak of the distribution of the SERT 
co-labeling with the V2a interneurons was about 3 microns from the V2a cell body (n=11 cells, 
Figure 6). Table 1 summarizes the average number of crossings for various radii measurements 
from the cell body.  
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Figure 4. Typical raw data distributions from single V2a Interneurons. A. Graph from Sholl Analysis for one V2a 
interneuron and 5-HT. B. Graph from Sholl Analysis for one V2a interneuron and SERT. 
A	   B	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Figure 5. Graph from Sholl analysis showing the average number of intersecting points of 5-HT and V2a processes. 
Figure 6. Graph from Sholl analysis showing the average number of intersecting points of SERT and V2a processes. 
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Table 1. Summary of Sholl Analysis for the Co-localization of V2a Interneurons and 5-HT (n=8 
cells) and of V2a Interneurons and SERT (n=11 cells) 
Radius from V2a Interneuron 
Cell Body (µm) 
Average Number of Crossings 
for 5-HT (mean ± SE) 
Average Number of Crossings 
for SERT (mean ± SE) 
0 0 ± 0 0 ± 0 
1 1 ± 0.423 2 ± 0.467 
2 3.375 ± 0.905 4.273 ± 0.702  
3 4.750 ± 1.161 5.091 ± 0.513 
4 4 ± 1.637 3.636 ± 0.877 
5 0.375 ± 0.264 1.091 ± 0.343 
6 0.250 ± 0.164 0.091 ± 0.091 
7 0.125 ± 0.125 0 ± 0 
  
 
Reduction in 5-HT and SERT after SCI	   
Although my previously described co-localization experiments seem to give evidence that SERT 
is located in 5-HT terminals, it was not determined whether all the SERT was located there. It is 
possible that some SERT is in glial or other non-5-HT cells. I wanted to determine if any SERT 
would be left after SCI, which should eliminate the 5-HT terminals, and if any SERT would 
remain in glial or other non-5-HT terminals. In order to determine how SCI changes expression 
levels of 5-HT and SERT, single immunohistochemical analyses of  5-HT and SERT in the 
medial lamina VIII region of matched pairs of intact and SCI mice were performed by myself 
and two other researchers in our lab (Figure 7A). While the serotonin immunofluorescence 
labeling was observed as fibrous staining in the axons of the descending raphe neurons in the 
control animals (Figure 7B; Carlsson et al., 1964), no fibrous staining was detected after SCI 
(Figure 7C; Carlsson et al., 1963). Both the serotonergic area, as measured by the percentage of 
pixels expressing 5-HT immunoreactivity, as well as the serotonergic fiber intensity, as measured 
by the subthreshold pixels surround the immunoreactive fibers, were significantly lower in SCI 
mice compared with intact mice. An 85% reduction in pixel number after SCI (p<0.05, matched-
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pair test, n=12) and an 84.6% reduction in pixel intensity after SCI (p<0.05, matched-pair test, 
n=12) was observed. This significant decrease in 5-HT expression was expected since the great 
majority of the serotonin in the spinal cord originates from the raphe neuron terminals, located in 
the brainstem (Carlsson et al., 1964) and this descending supply is cut by a complete SCI 
(Hayashi et al., 2010). With the loss of the descending 5-HT terminals after SCI, the majority of 
the SERT, which is found on 5-HT terminals (See Figure 2 above) and removes 5-HT from the 
synaptic cleft (Zhou et al., 1998), would also be expected to decrease. As expected, fibrous 
SERT immunostaining was significantly reduced after SCI. While fibrous SERT 
immunostaining was readily observed in the ventromedial cord of intact mice, less fibrous 
staining was detected after SCI (Figure 7G, Hayashi et al., 2010). As with the 5-HT 
immunostaining, both the SERT area and the SERT intensity were significantly lower in SCI 
mice compared with intact mice. A 51.4% reduction in pixel number after SCI (p<0.05, matched-
pair test, n=6) and a 49.4% reduction in pixel intensity after SCI (p<0.05, matched-pair test, n=6) 
was observed.  
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Figure 7. Reduction of 
serotonin (5-HT) and serotonin 
transporter (SERT) 
immunoreactivity after SCI. A. 
Spinal cord slice schematic with 
region of interest boxed around 
medial lamina VIII. B, C. 5-HT 
immunoreactivity from intact 
(B) and SCI (C) mice. D, E. 
Average area (D) and intensity 
(E) of 5-HT immunoreactivty in 
intact and SCI slices. F, G. 
SERT immunoreactivity from 
intact (F) and SCI (G) mice. H, 
I. Average area (D) and 
intensity (E) of SERT 
immunoreactivty in intact and 
SCI slices. *p<0.05, matched 
pair test, n=12 pairs for 5-HT 
and n=6 pairs for SERT. Scale 
bars: 10µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*The results listed under “Reduction in 5-HT and SERT after SCI” and Figure 7 were taken from 
Husch et al. (2012). 
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In order to test whether the remaining SERT labeling seen after SCI represented 
background non-specific labeling by the antibody or real expression of SERT in non-5-HT 
neurons, preabsorption controls were implemented. Preabsorption controls are used to verify the 
specificity of the SERT antibody to the mouse SERT peptide. In theory, all of the antibodies are 
inactivated since none are available to stain the SERT in the tissue with all of the antibodies 
binding to the peptide.  Preabsorption of the SERT antibody with the SERT peptide epitope used 
to raise the antibody eliminated virtually all labeling in intact cords.  In intact cords, while there 
was no difference between the preabsorption control and no-primary control, there was a 
significant difference between SERT labeling and the preabsorption control and between SERT 
labeling and no-primary control measures (p<0.05, One-way ANOVA, n=3, Figure 8). This 
illustrated that the SERT antibody is not showing a significant amount of non-specific binding to 
non-SERT antigens in intact spinal cord. In SCI cords, preliminary data using preabsorption of 
the SERT antibody with the SERT peptide epitope suggested that in SCI cords, the pre-absorbed 
antibody showed more immunofluorescence than the no-primary control. Empty black areas seen 
in Figure 9 are artifacts from the cryostat procedure and are not indicative of preabsorption 
control results. The difference between preabsorption of SERT antibody and no-primary control 
was not significant due to the low repetition number (n=3), but visual inspection suggested that 
the preabsorption control did show somewhat greater immunofluorescence than that of the no-
primary control (Figure 9). This result can help begin to differentiate between real SERT 
expression after SCI and non-specific binding of the antibody. Although the SERT preabsorption 
control reduced SERT immunostaining in SCI cords, it did not reduce immunostaining to the 
level seen in the no-primary control; there was no statistically significant difference between 
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immunostaining of SERT in SCI cords and in the preabsorption control. This suggests that some 
of the staining observed in SCI cords may not be true SERT signals. 
    
    
  Figure 8. Immunohistochemistry controls for SERT labeling in intact cords. A-C were obtained from the 
same animal. A. No-primary control. B. Preabsorption control. C. SERT staining in intact cord. D. Average 
area of SERT staining in three different conditions. Asterisk denotes a statistically significant difference. 
Preabsorption of the SERT peptide with antibody effectively eliminated immunostaining comparable to that of 
the no-primary control condition.   
A	  	   B	  
C	   D	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A	  	   B	  
C	  
Figure 9. Immunohistochemistry controls for SERT labeling in SCI cords. A-C were obtained from the same 
animal. A. No-primary control. B. Preabsorption control. C. SERT staining in SCI cord. D. Average area of 
SERT staining in three different conditions. Asterisk denotes a statistically significant difference (p<0.05). 
While there was a decrease in SERT immunosignaling with the preabsorption, the difference between the 
immunosignaling of SERT in SCI cords and that of the preabsorption condition was not significant. 
Furthermore, the difference between preabsorption of SERT antibody and no-primary control was not 
significant, by visual inspection, the preabsorption control had greater immunofluorescence than that of the 
no-primary control. 
D	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Discussion 
 
Spinal cord injury results in the loss of serotonergic fibers projecting from the brainstem 
to the spinal cord interneurons and motoneurons, and as a result, the concentration of 5-HT is 
significantly decreased in the spinal cord caudal to the lesion (Carlsson et al., 1963). In our 
single immunohistochemistry experiments, we expected to see significantly less 5-HT staining in 
SCI mice. Consistent with our hypothesis, four weeks after SCI, mice showed an 85% reduction 
in 5-HT expression as measured by pixel area, and an 84.6% reduction in 5-HT intensity in those 
pixels (Figure 7). Previous electrophysiological work has shown that V2a interneurons 
significantly increase their 5-HT sensitivity after SCI (Husch et al., 2012).  In both intact and 
SCI cords, V2a interneurons were perfused with 5-HT, followed by a wash period to allow for a 
recovery to baseline parameters before a higher concentration of 5-HT was applied (Husch et al., 
2012). V2a interneurons in intact cords did not significantly increase their firing rate with an 
application of 0.1 µM or 1 µM 5-HT, but 80% of these interneurons showed a significant 
increase in firing rate with an application of 10 µM 5-HT (Husch et al., 2012). In comparison, 
V2a interneurons in SCI cords significantly increased their firing rate with an application of as 
little as 10 nM 5-HT, reaching the maximal response at 0.1 µM 5-HT (Husch et al., 2012). With 
V2a interneurons in SCI cords showing a 100- to 1000- fold increase in 5-HT sensitivity, and 
with the fact that these interneurons are glutamatergic and excitatory to commissural 
interneurons and motoneurons, it is possible that greatly reduced presence of residual 5-HT in 
the spinal cord after SCI (Harvey PJ et al., 2006c) could account for this hypersensitivity (Husch 
et al., 2012). My double immunohistochemistry illustrating a clear co-localization of 5-HT  with 
V2a processes (Figure 4), provides more evidence that V2a interneurons are directly innervated 
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by descending serotonergic fibers under control conditions. Thus, it is possible that loss of 5-HT 
is playing a major role in changing V2a interneuron properties.  
From the double immunohistochemical staining of 5-HT with SERT in control spinal 
cords, I found that SERT strongly co-localizes with 5-HT axons, suggesting that most of the 
SERT is localized in serotonin terminals. Manders’ coefficients illustrated that approximately 
79% of the imaged SERT co-localized with the imaged 5-HT. This is a lower percentage than 
expected, since previous studies have shown that all the SERT is in 5-HT terminals. However, 
this may be explained by taking a closer look at the composite images (Figure 2C). Most of the 
red coloration from the SERT signal in the composite images surround the yellow pixels, or 
designated co-localized areas, and there are very few, if any, stand-alone red pixels. Furthermore, 
because Manders’ coefficients are known to be very sensitive to background signal and local 
variations in intensity, these coefficients are most accurate when the intensities of the two 
channels are of similar value. Manders’ coefficients thus illustrate when the intensity of one 
channel matches that of the second channel.  This would suggest that SERT is primarily 
expressed in 5-HT processes, and the low M2 coefficient is more an artifact of the analysis 
threshold than a physical localization difference.  The average M1 coefficient was 0.54, meaning 
approximately 54% of the imaged 5-HT co-localized with the imaged SERT. The fact that the 
M1 coefficient is less than the M2 coefficient illustrates that there is more 5-HT staining alone 
and not co-localizing with SERT. This may be because the areas of non-co-localization are the 
axonal pathways of 5-HT cells where SERT is not preferentially located, and the areas of co-
localization are terminal fields where the synapses are located (Zhou et al., 1998).  
Since I observed co-localization of SERT in 5-HT neuron processes (Figure 2), and 
similar co-localization patterns of SERT and V2a interneurons as 5-HT and V2a interneurons 
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(Figure 5 and 6), my finding of significantly reduced fibrous SERT immunostaining after SCI 
was expected. As with the 5-HT immunostaining, both the SERT area and the SERT intensity 
were significantly lower in SCI mice compared with intact mice. A 51.4% reduction in SERT 
area and a 49.4% reduction in SERT intensity were observed after SCI (Figure 7). This decrease 
in SERT immunoreactivity arises, in part, from the post-lesion degradation of serotonergic 
terminals as this is where SERT is primarily located (Zhou et al., 1998). Our results, differ from 
those of Hayashi et al. (2010), who observed a 99% loss of SERT in the ventral spinal cord after 
SCI in rats.  However, this may be due to some of our SERT labeling actually being nonspecific 
background staining of the SERT antibody. Evidence for this explanation is seen from SERT 
antibody preabsorption control experiments. In theory, because all of the antibody should bind to 
the peptide containing the SERT epitope and thus inactivate the antibody in the tissue, 
preabsorption of the antibody with the SERT peptide should eliminate all SERT 
immunostaining. Thus, if the SERT labeling after SCI is all non-specific binding of the SERT 
antibody to other antigens, then I expect that the amount of SERT staining in the preabsorption 
control would be similar to that of the non-preabsorbed SCI slice labeling.  In intact cords, there 
was a difference between SERT labeling and the preabsorption control and between SERT 
labeling and no-primary control measures, as expected if the SERT antibody is showing non-
specific binding to non-SERT antigens (Figure 8). The critical test was then to compare the 
SERT labeling in SCI cords before and after preabsorption of the SERT antibody by the SERT- 
specific epitope. The preabsorbed SERT labeling in SCI cords was more similar to the SERT 
labeling from the SCI cords than in the intact cords, and higher than the no-primary controls 
(Figure 9). This may suggest that the observed SERT antibody labeling after SCI may not be 
from true SERT signals, but from non-specific binding that is not removed by preabsorption with 
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the SERT epitope. The non-specific background staining may be due to residual necrotic tissue 
in the spinal cord that is more prone to non-specific binding. However, the absence of non-
specific staining using the 5-HT antibody argues against this hypothesis. Because my results 
seemed to show that there was more immunostaining in the SERT SCI cord than in the SCI 
preabsorbed control, both of which showed more immunostaining than the SCI no-primary 
control, this suggests that SERT may persist in non-5HT cells after SCI. However, these results 
are based on a low sample size (n=3), and more preabsorption control experiments must be 
performed in the future to make more conclusive observations.  
Though SERT and 5-HT may be interacting within the same areas of the V2a 
interneurons, the loss of SERT may not be as much of a contributing factor to the SCI-induced 
CPG interneuron changes as the loss of serotonin.  Previous electrophysiological experiments 
using citalopram, a SERT inhibitor, have shown that the loss of SERT on lesioned serotonergic 
terminals can only weakly account for the increase in 5-HT sensitivity (Husch et al., 2012). 
Applications of 0.1 µM, 1 µM, and 10 µM 5-HT to serotonin-sensitive control neurons treated 
with citalopram did not significantly increase firing rates (Husch et al., 2012). Because 5-HT 
sensitivity was not observed with the blockage of SERT, SERT loss is probably not  a major 
contributing factor to 5-HT sensitivity. 
With a complete sensory and motor function loss below the SCI site, axonal 
reconnections across the injury site and neural network maintenance below the injury site will be 
needed for a full recovery (Guertin, 2005).  However, there is currently no treatment available 
for complete recovery from SCI since there are no such significant natural regenerative processes 
taking place in the spinal cord after SCI which would correct the changes in intrinsic properties 
of locomotor CPG neurons that occur due to the loss of 5-HT and other descending inputs 
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(Guertin, 2005). With further studies exploring the function of CPGs and of the changes SCI 
induces, we can work to discover methods of appropriately adjusting neural responses to SCI to 
help treat the more than 500,000 people suffering from spinal cord injury (Guertin, 2005). 
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